Skip to Content
Top

BY Michael Hardy

Shortly after arriving at MD Anderson in 1987 as a junior faculty member, Guillermina Lozano, Ph.D., attended several seminars hosted by the center’s biochemistry department.

The biochemists giving the presentations were studying the role of transcription factors – proteins that regulate how genes express themselves. Lozano, a geneticist working to understand p53, a gene known to suppress tumor development, suddenly wondered if...

Guillermina ‘Gigi’ Lozano

BY Payal Pandit

Even as the rates of some cancers are falling, the United States is seeing a dramatic rise in skin cancer, which is now the most common cancer...

BY Clayton R. Boldt, Ph.D.

Each May, Skin Cancer Awareness Month serves as a reminder of how individuals can work to lower their risk of skin cancer – the most common...

BY Bryan Tutt

Patients with recurrent or second primary head and neck cancer who previously received radiation therapy to the head and neck region – especially those with unresectable tumors – have typically had a dismal prognosis and limited treatment options.

Although radiation therapy offers high rates of local disease control, re-irradiating the region is usually avoided for fear of damaging previously irradiated healthy tissue, including...

stereotactic body radiation therapy

BY Ron Gilmore

Triple-negative breast cancer (TNBC) is an aggressive form of the disease that doesn’t rely on the hormones estrogen and progesterone or the...

BY Clayton Boldt, Ph.D.

By July 31, all U.S. Department of Housing and Urban Development (HUD) housing will be required to be smokefree, in accordance to rule put...

BY Scott Merville

Immunotherapy has taken hold as an effective treatment for a variety of advanced cancers, but so far, colorectal cancer has...

BY Scott Merville

Immune cells that rush to repair damage caused by inflammatory tissue are subverted to cancer-promoting allies by pancreas cells that feature...

BY Clayton R. Boldt, Ph.D.

Fewer than 30% of the women in the U.S. with abnormal, benign lesions known as atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS...

BY Clayton R. Boldt, Ph.D.

Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of...